当前位置:首页 - 行情中心 - 欧林生物(688319) - 财务分析 - 利润表

欧林生物

(688319)

  

流通市值:92.88亿  总市值:93.00亿
流通股本:4.05亿   总股本:4.06亿

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入305,849,689.8287,490,281.98588,858,464.45386,646,898.48
  营业收入305,849,689.8287,490,281.98588,858,464.45386,646,898.48
二、营业总成本267,455,854.27103,562,135.21569,996,827.89379,815,023.64
  营业成本20,889,102.065,748,186.4632,707,434.8520,425,109.52
  税金及附加2,477,746.03512,277.033,716,416.722,226,976.66
  销售费用145,278,282.4541,886,928.76302,899,962.16185,241,304.11
  管理费用32,902,561.0122,743,811.4786,424,382.8563,044,731.6
  研发费用58,777,526.4729,123,911.81134,233,724.1999,399,717.64
  财务费用7,130,636.253,547,019.6810,014,907.129,477,184.11
  其中:利息费用7,455,488.083,719,578.7414,283,986.9910,383,811.72
  其中:利息收入425,415.39229,609.014,508,119.261,101,681.82
三、其他经营收益
  加:投资收益150,511.6470,592.05855,559.79500,625.69
  资产处置收益8,707.5--30,988.3-
  资产减值损失(新)491,601.371,271,436.022,936,350.795,074,024.15
  信用减值损失(新)-31,837,465.843,388,796.25-10,375,765.79-15,589,377.17
  其他收益7,484,305.74,297,791.769,063,439.563,702,801
四、营业利润14,691,495.92-7,043,237.1521,310,232.61519,948.51
  加:营业外收入5,958.531,703.811,140,439.081,044,193.66
  减:营业外支出14,669.24-146,971.33116,871.33
五、利润总额14,682,785.21-7,041,533.3422,303,700.361,447,270.84
  减:所得税费用1,452,994.79-6,583,013.041,530,181.21
六、净利润13,229,790.42-7,041,533.3415,720,687.32-82,910.37
(一)按经营持续性分类
  持续经营净利润13,229,790.42-7,041,533.3415,720,687.32-82,910.37
(二)按所有权归属分类
  归属于母公司股东的净利润13,196,891.47-7,073,911.7820,757,584.864,025,906.59
  少数股东损益32,898.9532,378.44-5,036,897.54-4,108,816.96
  扣除非经常损益后的净利润7,723,574.58-11,022,704.5911,180,820.89-332,098.12
七、每股收益
  (一)基本每股收益0.03-0.020.050.01
  (二)稀释每股收益0.03-0.020.050.01
九、综合收益总额13,229,790.42-7,041,533.3415,720,687.32-82,910.37
  归属于母公司股东的综合收益总额13,196,891.47-7,073,911.7820,757,584.864,025,906.59
  归属于少数股东的综合收益总额32,898.9532,378.44-5,036,897.54-4,108,816.96
公告日期2025-08-292025-04-262025-03-292024-10-30
审计意见(境内)标准无保留意见
TOP↑